fig4
![The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation](https://image.oaes.cc/ead3b69d-1022-4050-a1f8-f790983bc355/3988.fig.4.jpg)
Figure 4. Overall survival (A) and recurrence (B) rates following LT in reference to rituximab administration in patients with HCC. HCC: Hepatocellular carcinoma; MC: Milan criteria; LT: liver transplantation.
Figure 4. Overall survival (A) and recurrence (B) rates following LT in reference to rituximab administration in patients with HCC. HCC: Hepatocellular carcinoma; MC: Milan criteria; LT: liver transplantation.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/